Mats Christer Henriksson

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Pharmaceuticals Holding, Inc. is a pharmaceutical company based in Wilmington, DE. The private company develops pharmaceutical products.

Labesfal-Laboratórios Almiro SA is a pharmaceutical company based in Santiago de Besteiros, Portugal. Part of Fresenius SE & Co. KGaA, the Portuguese company develops, produces, and markets medical drugs and devices for therapy and the care of critical and chronic patients worldwide. The private company's product portfolio includes diabetes mellitus, critical disease, fluidotherapy, hepatic insufficiency, renal insufficiency, maldigestion/malabsorption, oncology, pediatrics, replacement nutritional support, medical devices, disposable devices, drainage manipulation technology, infusion technology, nutrition, enteric nutritional supplements, parenteral nutrition, specific amino acids, lipid emulsions, volume replacement, colloids, irrigation solutions, transfusion technology, and more. The company is committed to ethics, responsibility, compliance, diversity, integrity, safety, and social responsibility. The company also prioritizes career development and employee well-being.

Fresenius Kabi Italia Srl specializes in drugs and technologies for infusion, transfusion and clinical nutrition. The firm’s products include autologous, colloids, biosimilars, enteral nutrition, and infusion therapy. The company is headquartered in Isola della Scala, Italy.

Founded in 1966, FHC (Holdings) Ltd. is a British company that functions as an investment holding company. Part of Fresenius SE & Co. KGaA, the private company is based in Runcorn, UK.

Part of Else Kröner-Fresenius-Stiftung, Fresenius Kabi USA, Inc. develops, manufactures and delivers pharmaceuticals and medical devices. The private company is based in Wilmington, DE.

Founded in 1966, FHC (Holdings) Ltd. is a British company that functions as an investment holding company. Part of Fresenius SE & Co. KGaA, the private company is based in Runcorn, UK.

Labesfal-Laboratórios Almiro SA is a pharmaceutical company based in Santiago de Besteiros, Portugal. Part of Fresenius SE & Co. KGaA, the Portuguese company develops, produces, and markets medical drugs and devices for therapy and the care of critical and chronic patients worldwide. The private company's product portfolio includes diabetes mellitus, critical disease, fluidotherapy, hepatic insufficiency, renal insufficiency, maldigestion/malabsorption, oncology, pediatrics, replacement nutritional support, medical devices, disposable devices, drainage manipulation technology, infusion technology, nutrition, enteric nutritional supplements, parenteral nutrition, specific amino acids, lipid emulsions, volume replacement, colloids, irrigation solutions, transfusion technology, and more. The company is committed to ethics, responsibility, compliance, diversity, integrity, safety, and social responsibility. The company also prioritizes career development and employee well-being.

Founded in 1966, FHC (Holdings) Ltd. is a British company that functions as an investment holding company. Part of Fresenius SE & Co. KGaA, the private company is based in Runcorn, UK.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Pharmaceuticals Holding, Inc. is a pharmaceutical company based in Wilmington, DE. The private company develops pharmaceutical products.